BioSpace News Archive

Fluidigm Corporation today announced that it has entered into a non-exclusive distribution agreement with DNA Software, Inc. to provide CopyCount-CNV™ software for use with the Fluidigm Biomark™ HD system.

ANI Pharmaceuticals, Inc. today announced the launch of Candesartan Hydrochlorothiazide Tablets, 16mg/12.5mg, 32mg/12.5mg, and 32mg/25mg, an authorized generic of Atacand HCT®.

Firmenich Incorporated announced today that its wholly-owned U.S. subsidiary, Sentry Merger Sub, Inc., commenced the previously announced tender offer to acquire all of the outstanding common stock of Senomyx, Inc.

Ampio Pharmaceuticals, Inc. today provided an update of the ongoing Company activities required to file a Biologics License Application (BLA) for Ampion™ for the treatment of severe Osteoarthritis of the knee (OAK).

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, October 25, at 4:30 p.m.

DNAnexus, the global leader in biomedical informatics and data management, today announced the winners of the Mosaic Community Challenge: Clinical Strain Detection, which evaluated the accuracy of microbial strain detection in metagenomic samples.

The only computer-generated and fully automated charge infusion coding solution in healthcare today is now available in the Epic App Orchard.

eTrueNorth, the premier integrated pharmacy-based clinical services network, has launched a national program that will make it easier for employers to gather biometric data from employees as part of wellness programs.

MannKind Corporation (Nasdaq:MNKD), presented data from the STAT study (STudy comparing prandial insulin Aspart vs. Technosphere insulin in patients with type 1 diabetes on multiple daily injections) at the 54th Annual Meeting of the European Association for the Study of Diabetes

Predictive Technology Group, (OTC/PINK: PRED), a leader in the use of data analytics for disease identification enabling revolutionary therapeutic approaches, announces that its subsidiary, Predictive Diagnostics, will launch a unique endometriosis risk test this weekend at the 74th American Society of Reproductive Medicine (ASRM) Scientific Congress & Expo in Denver, Colorado.